| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2017 ( Subtotal = $0 ) |
| | 2017 | 2014 | METABOLIC SOLUTIONS DEVELOPMENT COMPANY | 161 E MICHIGAN AVE STE 400 | KALAMAZOO | MI | 49007-4832 | KALAMAZOO | USA | R43DK104508 | Therapeutic Use of mTOT Modulators in Polycystic Kidney Disease | 000 | 1 | NIH | 1/4/2017 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $121,956 ) |
| | 2014 | 2014 | METABOLIC SOLUTIONS DEVELOPMENT COMPANY | 3133 ORCHARD VISTA DRIVE SE | GRAND RAPIDS | MI | 49546 | KENT | USA | R43DK104508 | Therapeutic Use of mTOT Modulators in Polycystic Kidney Disease | 000 | 1 | NIH | 9/23/2014 | $121,956 |
|
| Issue Date FY: 2012 ( Subtotal = $610,998 ) |
| | 2012 | 2012 | METABOLIC SOLUTIONS DEVELOPMENT COMPANY | 3133 ORCHARD VISTA DRIVE SE | GRAND RAPIDS | MI | 49546 | KENT | USA | R42AA021228 | EVALUATION OF PPARGAM-SPARING TZDS FOR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 000 | 3 | NIH | 8/16/2012 | $560,998 |
| | 2012 | 2012 | METABOLIC SOLUTIONS DEVELOPMENT COMPANY | 3133 ORCHARD VISTA DRIVE SE | GRAND RAPIDS | MI | 49546 | KENT | USA | R42AA021228 | EVALUATION OF PPARGAM-SPARING TZDS FOR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 001 | 3 | NIH | 9/11/2012 | $50,000 |
|
| Issue Date FY: 2011 ( Subtotal = $1,198,115 ) |
| | 2011 | 2011 | METABOLIC SOLUTIONS DEVELOPMENT COMPANY | 3133 ORCHARD VISTA DRIVE SE | GRAND RAPIDS | MI | 49546 | KENT | USA | R42DK081298 | PPAR-SPARING/FREE THIAZOLIDINEDIONES FOR TREATMENT OF DIABETES | 001 | 3 | NIH | 6/3/2011 | $63,431 |
| | 2011 | 2011 | METABOLIC SOLUTIONS DEVELOPMENT COMPANY | 3133 ORCHARD VISTA DRIVE SE | GRAND RAPIDS | MI | 49546 | KENT | USA | R42DK081298 | PPAR-SPARING/FREE THIAZOLIDINEDIONES FOR TREATMENT OF DIABETES | 000 | 3 | NIH | 3/25/2011 | $570,880 |
| | 2011 | 2011 | METABOLIC SOLUTIONS DEVELOPMENT COMPANY | 3133 ORCHARD VISTA DRIVE SE | GRAND RAPIDS | MI | 49546 | KENT | USA | R42AA021228 | EVALUATION OF PPARGAM-SPARING TZDS FOR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 000 | 2 | NIH | 9/15/2011 | $563,804 |
|
| Issue Date FY: 2010 ( Subtotal = $608,312 ) |
| | 2010 | 2010 | METABOLIC SOLUTIONS DEVELOPMENT COMPANY | 3133 ORCHARD VISTA DRIVE SE | GRAND RAPIDS | MI | 49546 | KENT | USA | R42DK081298 | PPAR-SPARING/FREE THIAZOLIDINEDIONES FOR TREATMENT OF DIABETES | 000 | 2 | NIH | 3/31/2010 | $608,312 |
| | 2010 | 2009 | METABOLIC SOLUTIONS DEVELOPMENT COMPANY | 3133 ORCHARD VISTA DRIVE SE | GRAND RAPIDS | MI | 49546 | KENT | USA | R41DK084596 | EVALUATION OF PPARGAM-SPARING TZDS FOR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 000 | 1 | NIH | 2/24/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $280,775 ) |
| | 2009 | 2009 | METABOLIC SOLUTIONS DEVELOPMENT COMPANY | 3133 ORCHARD VISTA DRIVE SE | GRAND RAPIDS | MI | 49546 | KENT | USA | R41DK084596 | EVALUATION OF PPARGAM-SPARING TZDS FOR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 000 | 1 | NIH | 8/28/2009 | $140,911 |
| | 2009 | 2009 | METABOLIC SOLUTIONS DEVELOPMENT COMPANY | 3133 ORCHARD VISTA DRIVE SE | GRAND RAPIDS | MI | 49546 | KENT | USA | R42DK081298 | PPAR-SPARING/FREE THIAZOLIDINEDIONES FOR TREATMENT OF DIABETES | 000 | 1 | NIH | 4/23/2009 | $139,864 |
|
|
